Hypomethylating agents use in acute myeloid leukemia: A single-center experience

Context: Acute myeloid leukemia (AML) is a heterogeneous disease. Approximately 80% of older AML patients will die of their disease or its treatment with currently available antileukemic therapy because of the adverse prognostic risk factors. In elderly patients who are not candidates for induction...

Full description

Saved in:
Bibliographic Details
Main Authors: Sravan Kumar Bodepudi, Santhosh Kumar Devdas, Vinayak V Maka, Rasmi Palassery, Sumathi S Hiregoudar, Nalini Kilara
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=2;spage=202;epage=208;aulast=Bodepudi
Tags: Add Tag
No Tags, Be the first to tag this record!